摘要
抗心肌缺血联合用药不但可减少药物剂量,降低不良反应,而且还能加强或诱导心肌缺血预适应,降低心肌有害产物,抗心律失常,加强受损心肌或血管的修复,从而提高对心肌缺血的治疗效果。
The combination therapy of anti-myocardial ischemia has advantages of not only augmenting the therapy and reducing dose of some drugs, but also enhancing ing the the myocardial ischemia preconditioning, reducthe product which is of damage to the heart tissue and body, preventing the ischemic arrhythmias, and augmenting the rebuilding of the heart tissue and vessel tissue.
出处
《中国临床药理学与治疗学》
CAS
CSCD
2006年第8期847-850,共4页
Chinese Journal of Clinical Pharmacology and Therapeutics
关键词
心肌缺血
联合用药
缺血预适应
过氧化物
心律失常
心肌修复
myocardial ischemia
combination therapy
ischemia preconditioning
superoxide
ischemic arrhythmias
myocardial rebuilding